Biocon’s fundraising is viewed positively to manage debt. Expert Nischal Maheshwari is optimistic about Biocon’s future, expecting earlier investments to yield returns. He also favors contract development and manufacturing firms like Laurus Labs. Maheshwari sees potential in banking, metals, and power sectors, particularly execution-focused players in power.
F&O Talk: Smallcap index better placed than Nifty, says Sudeep Shah; picks 9 stocks for next week
SBI Securities expects Nifty’s breakout to strengthen if it crosses 24,450, opening the door to 24,900. While small-caps continue outperforming, Bank Nifty retains a positive